We believe that everyone - irrespective of who they are or where they live - deserve medications that work
Location: United Kingdom
Employees: 1-10
Total raised: $5M
Founded date: 2021
Investors 1
| Date | Name | Website |
| - | Merck Digi... | mds.studio |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 31.03.2023 | Seed | $5M | - |
Mentions in press and media 4
| Date | Title | Description |
| 04.04.2023 | Why Sofinnova is Betting on the Confluence of Digital Technology and the Life Sciences | With the advent and adoption of digital technologies, lines have long blurred among the world of devices, pharma and purely software-driven products. And now, one European venture capital firm has decided to bet on the future of this conver... |
| 31.03.2023 | BioCorteX Raises $5M in Seed Funding | BioCorteX, a London, UK-based digital medicine company that employs a first-principle computer simulation to understand drug-bacteria interactions and improve a person’s response to treatments, raised $5m in seed funding. The round was led ... |
| 31.03.2023 | BioCorteX raises $5 million to unlock drug-bacteria interactions | London-based bio-tech BioCorteX has raised $5 million in Seed funding. The funds will be used to further develop the company's Carbon Mirror platform which is a computer simulation to understand drug-bacteria interactions which hopes to imp... |
| - | BioCorteX | “home | BioCorteX” |